IP Library Granted Patent US 10,342,890
Granted Patent B2
US 10,342,890 · App. 14/451,316 · Granted Jul 9, 2019

Antibacterial wound dressing

Inventor: Roger Bray (Nuneaton, GB)
Assignee: CONVATEC LIMITED
A61L15/28A61L15/18A61L15/44A61L15/46A61L2300/104A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,342,890
App. No.
14/451,316
Granted
Jul 9, 2019
Kind
B2
Abstract

An antibacterial wound dressing is based on or derived from gel-forming fibers such as carboxymethyl cellulose or alginate fibers having silver ions linked thereto at some but not all of the exchangeable sites such that the distribution of silver ions over the exchangeable sites is substantially uniform. The silvered fibers for the wound dressing can be prepared by contacting an assembly of precursor gel-forming fibers having exchangeable sites under conditions which do not cause irreversible gelling of the fibers with an amount of a solution containing silver ions so as to link silver ions at some but not all of the exchangeable sites, the whole of the assembly of precursor gel-forming fibers being contacted essentially simultaneously with the entire solution containing silver ions.

Claims (10)

1. An antibacterial wound dressing derived from gel-forming fibres comprising silver ion-linked to exchangeable sites, wherein a distribution of silver ion over the exchangeable sites is substantially uniform, wherein a coloration of the wound dressing is substantially uniform over the dressing, and wherein the gel-forming fibres form a nonwoven web.

2. A wound dressing as claimed in claim 1 , wherein the silver ions are linked to not more than about 20% of the exchangeable sites on the gel-forming fibres.

3. A wound dressing as claimed in claim 1 , wherein the gel-forming fibres are carboxymethylated cellulose fibres.

4. A wound dressing as claimed in claim 1 , wherein the gel-forming fibres are calcium alginate or sodium/calcium alginate fibres.

5. A wound dressing as claimed in claim 3 , wherein the carboxymethylated cellulose fibres are derived from lyocell.

6. A wound dressing as claimed in claim 3 , wherein the carboxymethylated cellulose fibres has a degree of substitution of 0.1 to 0.5.

7. A wound dressing as claimed in claim 3 , wherein the carboxymethylated cellulose fibres has a degree of substitution of 0.2 to 0.4.

8. A wound dressing as claimed in claim 1 , wherein the silver content of the gel-forming fibres comprising silver ions linked to exchangeable sites is 0.01 to 10%.

9. A wound dressing as claimed in claim 1 , wherein the silver content of the gel-forming fibres comprising silver ions linked to exchangeable sites is 0.9 to 1.5%.

10. A wound dressing as claimed in claim 1 , wherein the nonwoven web of gel-forming fibres is needle bonded.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2019
From: WILMINGTON TRUST (LONDON) LIMITED
To: CONVATEC INC.; UNOMEDICAL A/S; UNOMEDICAL LIMITED
Reel/Frame 050831/0073 →
SECURITY AGREEMENT Recorded Nov 3, 2016
From: CONVATEC LIMITED; UNOMEDICAL A/S; UNOMEDICAL LIMITED
To: WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT
Reel/Frame 040551/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2015
From: BRAY, ROGER
To: ACORDIS SPECIALITY FIBRES LIMITED
Reel/Frame 035187/0179 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2015
From: ACORDIS SPECIALITY FIBRES LIMITED
To: CONVATEC LIMITED
Reel/Frame 035199/0615 →
Priority Claims (2)
GB 0121946.8 · Sep 12, 2001 · national
GB 0128329.0 · Nov 27, 2001 · national
Continuity (2)
Continuation 10488305
Related Publication 20140356454A1 · Dec 4, 2014
Cited By (2)
US 12,357,494 US 12,478,707